# Use of Gadolinium in CT Pulmonary Angiography

> **NCT02234375** · PHASE4 · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Pulmonary Embolism

## Interventions

- **DRUG:** Gadolinium

## Key facts

- **NCT ID:** NCT02234375
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-07
- **Primary completion:** 2018-12
- **Final completion:** 2019-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Gadolinium attenuation in vitro inadequate
- **Last updated:** 2020-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02234375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02234375, "Use of Gadolinium in CT Pulmonary Angiography". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02234375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*